Related references
Note: Only part of the references are listed.The MUC5B-associated variant rs35705950 resides within an enhancer subject to lineage- and disease-dependent epigenetic remodeling
Fabienne Gally et al.
JCI INSIGHT (2021)
Potential clinical utility of MUC5B und TOLLIP single nucleotide polymorphisms (SNPs) in the management of patients with IPF
Francesco Bonella et al.
ORPHANET JOURNAL OF RARE DISEASES (2021)
MUC5B promoter variant rs35705950 and rheumatoid arthritis associated interstitial lung disease survival and progression
Pierre-Antoine Juge et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2021)
Shared genetic etiology between idiopathic pulmonary fibrosis and COVID-19 severity
Joao Fadista et al.
EBIOMEDICINE (2021)
The minor T allele of the MUC5B promoter rs35705950 associated with susceptibility to idiopathic pulmonary fibrosis: a meta-analysis
Xiaozheng Wu et al.
SCIENTIFIC REPORTS (2021)
Lifetime risk of rheumatoid arthritis-associated interstitial lung disease in MUC5B mutation carriers
Antti Palomaki et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
DSP rs2076295 variants influence nintedanib and pirfenidone outcomes in idiopathic pulmonary fibrosis: a pilot study
Martina Doubkova et al.
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE (2021)
Prognostic role of MUC5B rs35705950 genotype in patients with idiopathic pulmonary fibrosis (IPF) on antifibrotic treatment
Davide Biondini et al.
RESPIRATORY RESEARCH (2021)
The MUC5B promoter risk allele for idiopathic pulmonary fibrosis predisposes to asbestosis
Mark G. J. P. Platenburg et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Chronic Hypersensitivity Pneumonitis, an Interstitial Lung Disease with Distinct Molecular Signatures
Haruhiko Furusawa et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Adjustment for index event bias in genome-wide association studies of subsequent events
Frank Dudbridge et al.
NATURE COMMUNICATIONS (2019)
Telomere length and genetic variant associations with interstitial lung disease progression and survival
Chad A. Newton et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Analysis of protein-altering variants in telomerase genes and their association with MUC5B common variant status in patients with idiopathic pulmonary fibrosis: a candidate gene sequencing study
Amy Dressen et al.
LANCET RESPIRATORY MEDICINE (2018)
Diagnosis of Idiopathic Pulmonary Fibrosis An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
The MUC5B promoter polymorphism and telomere length in patients with chronic hypersensitivity pneumonitis: an observational cohort-control study
Brett Ley et al.
LANCET RESPIRATORY MEDICINE (2017)
Management of suspected monogenic lung fibrosis in a specialised centre
Raphael Borie et al.
EUROPEAN RESPIRATORY REVIEW (2017)
Effect of Muc5b promoter polymorphism on disease predisposition and survival in idiopathic interstitial pneumonias
Joanne J. van der Vis et al.
RESPIROLOGY (2016)
Reduced mucociliary clearance in old mice is associated with a decrease in Muc5b mucin
Barbara R. Grubb et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2016)
CT Imaging Phenotypes of Pulmonary Fibrosis in the MUC5B Promoter Site Polymorphism
Jonathan H. Chung et al.
CHEST (2016)
An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis An Update of the 2011 Clinical Practice Guideline
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Epigenetics in lung fibrosis: from pathobiology to treatment perspective
Britney A. Helling et al.
CURRENT OPINION IN PULMONARY MEDICINE (2015)
Epigenetic regulation of ageing: linking environmental inputs to genomic stability
Berenice A. Benayoun et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2015)
Association Between the MUC5B Promoter Polymorphism and Survival in Patients With Idiopathic Pulmonary Fibrosis
Anna L. Peljto et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
A Multidimensional Index and Staging System for Idiopathic Pulmonary Fibrosis
Brett Ley et al.
ANNALS OF INTERNAL MEDICINE (2012)
Clinical Course and Prediction of Survival in Idiopathic Pulmonary Fibrosis
Brett Ley et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
An Official ATS/ERSARS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Index Event Bias as an Explanation for the Paradoxes of Recurrence Risk Research
Issa J. Dahabreh et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
A Common MUC5B Promoter Polymorphism and Pulmonary Fibrosis
Max A. Seibold et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Long-term clearance from small airways decreases with age
M Svartengren et al.
EUROPEAN RESPIRATORY JOURNAL (2005)
Share Paper
